{{Rsnum
|rsid=1076562
|Gene=DRD2
|Chromosome=11
|position=113425286
|Orientation=plus
|GMAF=0.4187
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=DRD2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 5.3 | 36.3 | 58.4
| HCB | 30.7 | 44.5 | 24.8
| JPT | 25.7 | 54.0 | 20.4
| YRI | 36.7 | 45.6 | 17.7
| ASW | 15.8 | 52.6 | 31.6
| CHB | 30.7 | 44.5 | 24.8
| CHD | 23.9 | 54.1 | 22.0
| GIH | 14.9 | 49.5 | 35.6
| LWK | 47.3 | 41.8 | 10.9
| MEX | 5.2 | 39.7 | 55.2
| MKK | 32.7 | 49.4 | 17.9
| TSI | 3.9 | 35.3 | 60.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=21095016
|Title=Association of DRD2 and ANKK1 polymorphisms with prolactin increase in olanzapine-treated women
}}

{{PMID Auto
|PMID=17105675
|Title=The relationship between the therapeutic response to risperidone and the dopamine D2 receptor polymorphism in Chinese schizophrenia patients.
}}

{{on chip | Illumina Human 1M}}